Memantine improves cognitive deficits via K
CaMKII
CaMKIV
Cognitive deficits
K(ATP) channel
Memantine
OBX mice
Journal
Molecular and cellular neurosciences
ISSN: 1095-9327
Titre abrégé: Mol Cell Neurosci
Pays: United States
ID NLM: 9100095
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
19
03
2021
revised:
20
10
2021
accepted:
21
10
2021
pubmed:
30
10
2021
medline:
14
1
2022
entrez:
29
10
2021
Statut:
ppublish
Résumé
Patients with Alzheimer's disease (AD) demonstrate severely impaired olfactory systems, which occur in the early stages of the disease. Olfactory bulbectomy (OBX) in mice elicits cognitive deficits, and reduces cholinergic activity in the hippocampus. Here, we confirmed that the novel AD drug memantine rescues cognitive deficits via ATP-sensitive potassium (K
Identifiants
pubmed: 34715352
pii: S1044-7431(21)00093-2
doi: 10.1016/j.mcn.2021.103680
pii:
doi:
Substances chimiques
Adenosine Triphosphate
8L70Q75FXE
Memantine
W8O17SJF3T
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103680Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.